Becton, Dickinson reported strong quarterly results, exceeding estimates and lifting its full-year earnings forecast amid AI-driven efficiency gains.
Becton, Dickinson (NYSE:BDX) posted a quarterly earnings beat, driving shares up nearly 6% as the company raised its full-year earnings guidance. The medical technology firm cited strong execution and demand for AI-powered solutions that help hospitals optimize operations with fewer staff.
The results surpassed both top- and bottom-line expectations, marking a sharp improvement after five years of steady growth. Management attributed the performance to broad-based strength across its medical supplies, diagnostics, and lab equipment segments.
The stock’s gain stood out in a weak market session, reflecting investor confidence in BDX’s ability to leverage AI and automation trends in healthcare.